IRIS
PEDICA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.817
NA - Nord America 1.020
EU - Europa 906
SA - Sud America 338
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.113
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 933
SG - Singapore 826
CN - Cina 549
IT - Italia 367
BR - Brasile 283
HK - Hong Kong 191
DE - Germania 111
VN - Vietnam 90
RU - Federazione Russa 82
GB - Regno Unito 61
FI - Finlandia 59
SE - Svezia 55
CA - Canada 48
IN - India 42
NL - Olanda 37
MX - Messico 33
AT - Austria 30
PL - Polonia 28
BD - Bangladesh 25
AR - Argentina 22
JP - Giappone 18
FR - Francia 16
TR - Turchia 15
ES - Italia 13
ZA - Sudafrica 13
EC - Ecuador 11
IE - Irlanda 10
LT - Lituania 9
IQ - Iraq 8
BE - Belgio 7
PK - Pakistan 7
CH - Svizzera 6
ID - Indonesia 6
UZ - Uzbekistan 6
PY - Paraguay 5
TH - Thailandia 5
UY - Uruguay 5
VE - Venezuela 5
JM - Giamaica 4
TW - Taiwan 4
UA - Ucraina 4
DZ - Algeria 3
KE - Kenya 3
KR - Corea 3
MY - Malesia 3
PE - Perù 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
BH - Bahrain 2
CL - Cile 2
DK - Danimarca 2
GH - Ghana 2
IL - Israele 2
KH - Cambogia 2
RO - Romania 2
SA - Arabia Saudita 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CO - Colombia 1
CY - Cipro 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
IR - Iran 1
JO - Giordania 1
KZ - Kazakistan 1
MA - Marocco 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.113
Salva come PNG Salva come JPEG
Città #
Singapore 534
Hong Kong 189
Ashburn 154
Dallas 140
Shanghai 119
Milan 110
Beijing 104
Hefei 81
Los Angeles 54
New York 53
Boardman 42
Munich 35
Ho Chi Minh City 31
Santa Clara 28
São Paulo 28
Helsinki 27
Rome 26
Warsaw 26
Nuremberg 24
Moscow 23
London 21
Hanoi 19
Lappeenranta 19
Montreal 19
Brooklyn 18
Orem 18
Vienna 18
Tokyo 17
Denver 16
Toronto 16
Guangzhou 15
Mexico City 14
Houston 13
Turku 13
Chicago 12
Stockholm 12
Amsterdam 11
Ankara 11
Falkenstein 11
Johannesburg 11
Lawrence 11
Poplar 11
Princeton 11
Romagnano Sesia 11
Seattle 11
Atlanta 10
Chennai 10
Boston 9
Cesano Boscone 9
Dublin 9
Frankfurt am Main 8
Brussels 7
Genoa 7
Mugnano di Napoli 7
San Francisco 7
Belo Horizonte 6
Cagliari 6
Guarulhos 6
Jiaxing 6
Manchester 6
Parma 6
Phoenix 6
Rio de Janeiro 6
Tashkent 6
Trento 6
Xi'an 6
Bergamo 5
Bologna 5
Da Nang 5
Gatchina 5
Monza 5
Ottawa 5
Rho 5
Shenzhen 5
Charlotte 4
Dhaka 4
Haiphong 4
Hyderabad 4
Jakarta 4
Khon Kaen 4
Kingston 4
Montevideo 4
Mumbai 4
New Delhi 4
Porto Alegre 4
St Petersburg 4
Turin 4
Wuxi 4
Xiamen 4
Assago 3
Asunción 3
Augusta 3
Baghdad 3
Baltimore 3
Brasília 3
Brescia 3
Castelfranco Emilia 3
Changsha 3
Council Bluffs 3
Duque de Caxias 3
Totale 2.469
Salva come PNG Salva come JPEG
Nome #
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 126
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 124
A complex case of severe acute hepatitis with cholestasis in a genetically predisposed woman: Could curcumin be the trigger? 97
Pathology and molecular pathology of cholangiocarcinoma 96
Acute and Chronic Manifestations of Sympathetic Ophthalmia on Multimodal Imaging 82
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 81
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations 79
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity 73
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 72
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 72
Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib 71
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 70
Gene-Based Immune Reprogramming Overcomes the Immunosuppressive Microenvironment of Liver Metastases and Enables Protective T Cell Responses 66
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 66
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 66
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 66
N-Glycosylation Inhibition Hinders Immunosuppressive Activity of Tumor Microenvironment Cells and Improves CAR T Cell Efficacy 66
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study 64
A Re-Emerging Marker for Prognosis in Hepatocellular Carcinoma: The Add-Value of FISHing c-myc Gene for Early Relapse 62
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 62
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis 61
Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies 60
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions 60
Defining and predicting textbook outcomes for perihilar cholangiocarcinoma: analysis of factors improving achievement of desired postoperative outcomes 60
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 59
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 58
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 57
Cervix neuroendocrine carcinoma presenting with severe hypokalemia and Cushing’s syndrome 57
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 56
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime 56
Cholangiocarcinoma: new perspectives for new horizons 56
The real life of precision medicine in biliary tract cancers: a tertiary referral centre experience 56
Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos 55
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? 55
HCC in metabolic syndrome: current concepts and future directions 53
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 53
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming 52
Association of IgG4-related disease and systemic rheumatic disorders 49
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease 49
IFNalpha by In Vivo-Engineered Macrophages Abates Liver Metastases and Triggers Counter Regulatory Responses Limiting Efficacy 48
Minimally Invasive Approach Provides Oncological Benefit in Patients with High Risk of Very Early Recurrence (VER) After Surgery for Intrahepatic Cholangiocarcinoma (iCCA) 48
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)] 47
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming 47
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 47
Repeated administration of the food additive E171 to mice results in accumulation in intestine and liver and promotes an inflammatory status 47
The oncologic burden of residual disease in incidental gallbladder cancer: An elastic net regression model to profile high-risk features 47
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection 46
3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations 46
Subcutaneous dirofilariosis in Italy: a diagnostic hypothesis to remind when the anamnesis is misleading 45
PDX-1 (Pancreatic/Duodenal Homeobox-1 Protein 1) 45
Late Breaking Abstract - Morphological and immunophenotypical features of lung tissue in early phase of COVID-19 45
Age influence on mice lung tissue response to Aspergillus fumigatus chronic exposure 44
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 44
Pure and mixed gallbladder neuroendocrine neoplasms: rare and orphan lesions 43
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma 42
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination 41
Hydroxyapatite/collagen composite is a reliable material for malar augmentation 41
Endocrine neoplasms of the pancreas: pathologic and genetic features. 41
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis. 40
Clinicopathological features of adenosquamous pancreatic cancer 39
Mucinous cystic neoplasms of the liver: A clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct 39
Lymphangiogenesis in Crohn's disease: An immunohistochemical study using monoclonal antibody D2-40 38
IFNalpha by in vivo-engineered macrophages abates liver metastases and triggers counter regulatory responses limiting efficacy 38
Total portal vein replacement with peritoneal interposition graft during Whipple’s procedure for extrahepatic cholangiocarcinoma: a technical report 37
Survival Outcomes of Durvalumab in Combination with Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer: Real-World Results from a Single Italian Institution 37
Heterogeneity of response and immune system activity during treatment with nivolumab in hepatocellular carcinoma: Results from a single-institution retrospective analysis 37
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease 36
Peribiliary glands pathology in a large series of end-stage alcohol-related liver disease 35
Preliminary results of the influence of the in vivo use of a lymphatic dye (Patent Blue V) in the surgical treatment of Crohn's disease 35
Toxicity profile of adjuvant hypofractionated Image-Guided Radiotherapy in biliary tract carcinoma 34
Paraoxonase-1 status in patients with hereditary hemochromatosis 34
Massive retinal gliosis in a young woman with congenital toxoplasmosis 33
Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE) 32
IgG4-related autoimmune liver disease 31
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma 31
Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma 31
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib 30
Programmed death 1 (PD-1) and its ligand (PD-L1) as a new frontier in cancer Immunotherapy and challenges for the Pathologist: State of the art 29
Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report 29
Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: A case report and review of the literature 24
Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes 23
Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? 23
Next-generation histopathologic diagnosis: A lesson from a hepatic carcinosarcoma 21
Surgery for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: milestone changes in the last two decades potentially affecting current guidelines 13
Totale 4.306
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.589
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 1 0 0 0 0 0
2021/202214 0 0 2 3 0 2 2 1 1 2 0 1
2022/202382 25 16 9 0 1 15 5 4 7 0 0 0
2023/2024449 11 65 50 41 20 33 19 42 4 18 64 82
2024/20251.506 169 41 63 69 85 117 260 177 170 86 112 157
2025/20262.248 355 306 217 620 601 149 0 0 0 0 0 0
Totale 4.306